Interleukin 3D structures
From Proteopedia
(Difference between revisions)
| (4 intermediate revisions not shown.) | |||
| Line 10: | Line 10: | ||
**[[2l5x]] – hIL-1 α residues 121-271 + calcium-binding protein A13 – NMR<BR /> | **[[2l5x]] – hIL-1 α residues 121-271 + calcium-binding protein A13 – NMR<BR /> | ||
| - | *IL-1 β | + | *Mature IL-1 β (residues 117-269) |
| - | **[[ | + | **[[1i1b]], [[1iob]], [[2i1b]], [[2nvh]], [[3ltq]], [[4ilb]], [[5i1b]], [[8rys]], [[9i1b]] - hIL-1 β |
| - | + | **[[3ltq]], [[8rys]] - hIL-1 β <BR /> | |
**[[6i1b]], [[7i1b]] - hIL-1 β - NMR<BR /> | **[[6i1b]], [[7i1b]] - hIL-1 β - NMR<BR /> | ||
| - | **[[ | + | **[[1hib]], [[1l2h]], [[1s0l]], [[1t4q]], [[1tp0]], [[1too]], [[1twe]], [[1twm]], [[21bi]], [[31bi]], [[3pok]], [[41bi]] - hIL-1 β (mutant) <BR /> |
| - | + | **[[6y8i]], [[6y8m]], [[8c3u]], [[8rzb]] - hIL-1 β + pyridine derivative<BR /> | |
| - | **[[6y8i]], [[6y8m]] - hIL-1 β | + | **[[8ryk]] - hIL-1 β + peptide<BR /> |
**[[1itb]] - hIL-1 β + IL-1 receptor 1 extracellular domain<BR /> | **[[1itb]] - hIL-1 β + IL-1 receptor 1 extracellular domain<BR /> | ||
**[[3o4o]] - hIL-1 β + IL-1 receptor 2 + IL-1 receptor accessory protein<BR /> | **[[3o4o]] - hIL-1 β + IL-1 receptor 2 + IL-1 receptor accessory protein<BR /> | ||
**[[4dep]] - hIL-1 β + IL-1 receptor 1 + IL-1 receptor accessory protein<BR /> | **[[4dep]] - hIL-1 β + IL-1 receptor 1 + IL-1 receptor accessory protein<BR /> | ||
| - | **[[4g6j]], [[4g6m]], [[5bvp]] - hIL-1 β + antibody<br /> | + | **[[4g6j]], [[4g6m]], [[5bvp]], [[7chy]], [[7chz]], [[7z4t]] - hIL-1 β + antibody<br /> |
| - | **[[2kh2]] - hIL-1 β + | + | **[[2kh2]] - hIL-1 β + scFv - NMR<BR /> |
| - | + | **[[2mib]], [[8i1b]] - mIL-1 β - mouse | |
| - | **[[2mib]], [[8i1b]] - mIL-1 β | + | |
**[[2wry]] - cIL-1 β – chicken<BR /> | **[[2wry]] - cIL-1 β – chicken<BR /> | ||
| - | **[[3nj5]], [[ | + | **[[3nj5]], [[4x37]], [[4x38]], [[4x39]], [[4x3a]] – cIL-1 β (mutant) <BR /> |
*IL-2 (T-cell growth factor) | *IL-2 (T-cell growth factor) | ||
**[[1m47]], [[1m4c]], [[3ink]] – hIL-2<BR /> | **[[1m47]], [[1m4c]], [[3ink]] – hIL-2<BR /> | ||
| - | **[[3qb1]] - hIL-2 (mutant)<br /> | + | **[[3qb1]], [[7m2g]], [[7ra9]], [[7raa]] - hIL-2 (mutant)<br /> |
**[[1irl]] – hIL-2 (mutant) - NMR<BR /> | **[[1irl]] – hIL-2 (mutant) - NMR<BR /> | ||
**[[5m5e]] - hIL-2 + IL-2 receptor β + cytokine receptor common γ<BR /> | **[[5m5e]] - hIL-2 + IL-2 receptor β + cytokine receptor common γ<BR /> | ||
| Line 40: | Line 39: | ||
**[[1pw6]], [[1py2]], [[1m48]], [[1m49]] – hIL-2 + inhibitor<BR /> | **[[1pw6]], [[1py2]], [[1m48]], [[1m49]] – hIL-2 + inhibitor<BR /> | ||
**[[4nej]], [[4nem]] – hIL-2 + methylfuran carboxylate derivative<BR /> | **[[4nej]], [[4nem]] – hIL-2 + methylfuran carboxylate derivative<BR /> | ||
| - | **[[5lqb]] - hIL-2 + antibody<br /> | + | **[[5lqb]], [[6ye3]], [[7dr4]] - hIL-2 + antibody<br /> |
| + | **[[8sow]], [[8soz]] - hIL-2 + scFv<br /> | ||
| + | **[[7zmz]] - hIL-2 + CD25<br /> | ||
**[[4yue]] - mIL-2 + antibody<br /> | **[[4yue]] - mIL-2 + antibody<br /> | ||
**[[4yqx]] - IL-2 + antibody - rat<br /> | **[[4yqx]] - IL-2 + antibody - rat<br /> | ||
**[[4zf7]] – hIL-2 - ferret<BR /> | **[[4zf7]] – hIL-2 - ferret<BR /> | ||
| + | **[[7cjn]], [[7d9m]] – IL-2 – grass carp<BR /> | ||
*IL-3 | *IL-3 | ||
| Line 54: | Line 56: | ||
*IL-4 | *IL-4 | ||
| - | **[[ | + | **[[1hik]], [[1rcb]], [[2b8u]], [[2int]] – hIL-4<BR /> |
| - | **[[ | + | **[[1bbn]], [[1bcn]], [[1cyl]], [[1iti]], [[1itl]], [[1itm]], [[2cyk]], [[8cgf]], [[8ch7]] – hIL-4 - NMR<BR /> |
| - | **[[2b8x]], [[2b8y]], [[2b8z]], [[2b90]], [[2b91]], [[2d48]], [[ | + | **[[1hij]], [[1hzi]], [[2b8x]], [[2b8y]], [[2b8z]], [[2b90]], [[2b91]], [[2d48]], [[8a4f]] - hIL-4 (mutant) <BR /> |
**[[5fhx]] - hIL-4 + antibody<BR /> | **[[5fhx]] - hIL-4 + antibody<BR /> | ||
**[[1iar]] - hIL-4 + IL-4 receptor α (mutant) <BR /> | **[[1iar]] - hIL-4 + IL-4 receptor α (mutant) <BR /> | ||
| Line 70: | Line 72: | ||
**[[3qt2]] - hIL-5 + IL-5 receptor α (mutant) <BR /> | **[[3qt2]] - hIL-5 + IL-5 receptor α (mutant) <BR /> | ||
**[[3va2]] - hIL-5 + IL-5 receptor α <BR /> | **[[3va2]] - hIL-5 + IL-5 receptor α <BR /> | ||
| + | **[[8tld]] - hIL-5 + IL-5 receptor α + cytokine receptor subunit beta – Cryo EM <BR /> | ||
**[[3b5k]] – mIL-5<br /> | **[[3b5k]] – mIL-5<br /> | ||
*IL-6 | *IL-6 | ||
| - | **[[1alu]] – hIL-6<BR /> | + | **[[1alu]], [[7nxz]] – hIL-6<BR /> |
**[[1il6]], [[2il6]] – hIL-6 - NMR<BR /> | **[[1il6]], [[2il6]] – hIL-6 - NMR<BR /> | ||
| + | **[[8qy6]] – hIL-6 – Cryo EM<BR /> | ||
**[[1p9m]] - hIL-6 + IL-6 receptor α and β<br /> | **[[1p9m]] - hIL-6 + IL-6 receptor α and β<br /> | ||
| + | **[[8d82]], [[8qy5]] - hIL-6 + IL-6 receptor α and β – Cryo EM<br /> | ||
**[[5fuc]] - hIL-6 + IL-6 receptor α + VHH6<br /> | **[[5fuc]] - hIL-6 + IL-6 receptor α + VHH6<br /> | ||
**[[4j4l]] – hIL-6 + internalin B<BR /> | **[[4j4l]] – hIL-6 + internalin B<BR /> | ||
**[[4ni7]], [[4ni9]] – hIL-6 + nucleotide aptamer<BR /> | **[[4ni7]], [[4ni9]] – hIL-6 + nucleotide aptamer<BR /> | ||
| - | **[[4cni]], [[4o9h]], [[4zs7]] – hIL-6 + antibody<BR /> | + | **[[4cni]], [[4o9h]], [[4zs7]], [[8ywq]] – hIL-6 + antibody<BR /> |
| + | **[[8ywr]] – hIL-6 42-212 + antibody<BR /> | ||
**[[2l3y]] - mIL-6 residues 27-211 - NMR<br /> | **[[2l3y]] - mIL-6 residues 27-211 - NMR<br /> | ||
| - | **[[1i16]] – IL-6 + IL-6 receptor β - Herpesvirus 8<br /> | + | **[[1i16]] – IL-6 + IL-6 receptor β - Herpesvirus 8 |
| + | **[[8upa]] – sIL-6 1-56 + hIL-6 receptor β – synthetic<br /> | ||
*IL-7 | *IL-7 | ||
| Line 95: | Line 102: | ||
**[[1ikl]], [[1ikm]] - hIL-8 (mutant) - NMR<BR /> | **[[1ikl]], [[1ikm]] - hIL-8 (mutant) - NMR<BR /> | ||
**[[3il8]], [[5d14]], [[4xdx]] – hIL-8 residues 28-99<BR /> | **[[3il8]], [[5d14]], [[4xdx]] – hIL-8 residues 28-99<BR /> | ||
| + | **[[6xmn]] – hIL-8 residues 28-93 + CXCR1 N-terminal - NMR<BR /> | ||
**[[1rod]] - hIL-8/melanoma growth stimulating protein – NMR<br /> | **[[1rod]] - hIL-8/melanoma growth stimulating protein – NMR<br /> | ||
| - | **[[1ilp]], [[1ilq]] - hIL-8 + IL-8 receptor peptide | + | **[[1ilp]], [[1ilq]] - hIL-8 + IL-8 receptor peptide<br /> |
| + | **[[6wzm]] – hIL-8 + antibody<BR /> | ||
| + | **[[6lfm]], [[6lfo]]– hIL-8 in G-protein coupled receptor – Cryo EM<br /> | ||
| + | |||
| + | *IL-9 | ||
| + | |||
| + | **[[7ox6]] – hIL-9 - NMR<BR /> | ||
| + | **[[7ox5]] - hIL-9 + IL—9 receptor a<br /> | ||
| + | **[[7ox1]], [[7ox2]], [[7ox3]] - hIL-9 + antibody<br /> | ||
| + | **[[7xcb]] – mIL-9 <BR /> | ||
| + | **[[7ox4]] – mIL-9 + antibody<BR /> | ||
*IL-10 | *IL-10 | ||
| Line 103: | Line 121: | ||
**[[1j7v]] – hIL-10 + IL-10 receptor α (mutant) <BR /> | **[[1j7v]] – hIL-10 + IL-10 receptor α (mutant) <BR /> | ||
**[[1y6k]] - hIL-10 residues 19-178 + IL-10 receptor α<br /> | **[[1y6k]] - hIL-10 residues 19-178 + IL-10 receptor α<br /> | ||
| + | **[[8sve]] – hIL-10 + antibody<BR /> | ||
**[[4x51]] – mIL-10<BR /> | **[[4x51]] – mIL-10<BR /> | ||
| Line 116: | Line 135: | ||
**[[4mhl]] - hIL-11<br /> | **[[4mhl]] - hIL-11<br /> | ||
| + | **[[8dpv]], [[8dpw]] - hIL-11 (mutant) <br /> | ||
| + | **[[8qy4]] - hIL-11 (mutant) – Cryo EM<br /> | ||
| + | **[[8dpu]] - hIL-11 + hILR-11 alpha+beta <br /> | ||
| + | **[[8dps]] - hIL-11 + hILR-11 alpha+beta – Cryo EM<br /> | ||
| + | **[[8dpt]] - hIL-11 + hILR-11 alpha (mutant) + hILR-6 – Cryo EM<br /> | ||
*IL-12 | *IL-12 | ||
| Line 122: | Line 146: | ||
**[[1f42]] - hIL-12 β P40 domain<BR /> | **[[1f42]] - hIL-12 β P40 domain<BR /> | ||
**[[3hmx]] - hIL-12 α and β+ antibody<br /> | **[[3hmx]] - hIL-12 α and β+ antibody<br /> | ||
| + | **[[8pb1]], [[8yi7]] - hIL-12 α and β+ hILR-12 α and β – Cryo EM<br /> | ||
| + | **[[8oe0]], [[8xrp]] – hIL-12 α and β + hIL12R beta1 and beta2 – Cryo EM<br /> | ||
**[[5mj3]], [[5mj4]], [[5njd]] - hIL-12 β + hIL-23 α + antibody<br /> | **[[5mj3]], [[5mj4]], [[5njd]] - hIL-12 β + hIL-23 α + antibody<br /> | ||
**[[5mzv]] - hIL-12 β + hIL-23 α + hIL-23 receptor + antibody<br /> | **[[5mzv]] - hIL-12 β + hIL-23 α + hIL-23 receptor + antibody<br /> | ||
| - | **[[ | + | **[[6wdq]] - hIL-12 β + hIL-23 α + hIL-12 receptor + hIL-23 receptor <br /> |
| - | **[[ | + | **[[8oe4]] - hIL-12 β + hIL-23 α + hIL-12 receptor + hIL-23 receptor – Cryo EM <br /> |
| + | **[[5mxa]], [[8cr8]] - hIL-12 β + hIL- 23 α<br /> | ||
**[[3qwr]] - hIL-12 β + hIL- 23 α + adnectin<br /> | **[[3qwr]] - hIL-12 β + hIL- 23 α + adnectin<br /> | ||
| - | **[[6uib]] - hIL-12 β + hIL- 23 α + peptide<br /> | + | **[[6uib]], [[8uui]] - hIL-12 β + hIL- 23 α + peptide<br /> |
| - | **[[6sff]] - mIL-12 β <br /> | + | **[[8cr6]] - mIL-12 alpha + beta subunits <br /> |
| + | **[[6sff]], [[6smc]], [[6sp3]], [[7pur]], [[7r3n]] - mIL-12 β <br /> | ||
| + | **[[8cr5]] - mIL-12 alpha+β + mILR-12 beta1+ beta2 – Cryo EM<br /> | ||
| + | **[[8odz]] - mIL-12 β + mILR-12 beta1 <br /> | ||
*IL-13 | *IL-13 | ||
| Line 137: | Line 167: | ||
**[[3lb6]] - hIL-13 + IL-13 receptor α2<BR /> | **[[3lb6]] - hIL-13 + IL-13 receptor α2<BR /> | ||
**[[3bpo]], [[5e4e]] - hIL-13 residues 20-145 + IL-4 receptor α + IL-13 receptor α<br /> | **[[3bpo]], [[5e4e]] - hIL-13 residues 20-145 + IL-4 receptor α + IL-13 receptor α<br /> | ||
| - | **[[5l6y]] - hIL-13 + antibody<br /> | + | **[[5l6y]], [[7rew]] - hIL-13 + antibody<br /> |
| + | **[[8blq]] - hIL-13 + antibody – Cryo EM<br /> | ||
*IL-15 | *IL-15 | ||
| Line 154: | Line 185: | ||
**[[4hr9]] - hIL-17A (mutant)<br /> | **[[4hr9]] - hIL-17A (mutant)<br /> | ||
**[[5n92]] - hIL-17A + hIL-17F <br /> | **[[5n92]] - hIL-17A + hIL-17F <br /> | ||
| + | **[[7uwm]] - hIL-17A + IL-17A receptor α – Cryo EM<br /> | ||
**[[4hsa]] - hIL-17A (mutant) + IL-17A receptor α <br /> | **[[4hsa]] - hIL-17A (mutant) + IL-17A receptor α <br /> | ||
**[[5nan]] - hIL-17A + hIL-17F + IL-17A receptor α <br /> | **[[5nan]] - hIL-17A + hIL-17F + IL-17A receptor α <br /> | ||
| - | **[[2vxs]], [[4qhu]] - hIL-17A + antibody<BR /> | + | **[[7uwn]] - hIL-17A + IL-17A receptor α + IL-17A receptor gamma<br /> |
| + | **[[7zan]] - hIL-17A (mutant) + IL-17A receptor α + IL-17A receptor gamma<br /> | ||
| + | **[[2vxs]], [[4qhu]], [[6wio]], [[6wir]], [[7wkx]], [[7z2m]] - hIL-17A + antibody<BR /> | ||
| + | **[[8b7w]], [[8dy1]], [[8dy5]] - hIL-17A + scFv<BR /> | ||
| + | **[[8dyf]], [[8dyg]], [[8dyh]], [[8dyi]], [[8usr]], [[8uss]], [[9fkx]], [[9fl3]], [[9h4d]], [[9h4o]] - hIL-17A + inhibitor<BR /> | ||
**[[5vb9]] - hIL-17A + peptide inhibitor<BR /> | **[[5vb9]] - hIL-17A + peptide inhibitor<BR /> | ||
| + | **[[8cdg]] - hIL-17A + macrocycle inhibitor<BR /> | ||
| + | **[[7ama]], [[7amg]] - hIL-17A + modulator<br /> | ||
**[[5hi5]], [[5hi4]], [[5hi3]], [[5hhx]], [[5hhv]] - hIL-17A + peptide inhibitor + antibody<BR /> | **[[5hi5]], [[5hi4]], [[5hi3]], [[5hhx]], [[5hhv]] - hIL-17A + peptide inhibitor + antibody<BR /> | ||
**[[1jpy]], [[6hgo]] – hIL-17F<BR /> | **[[1jpy]], [[6hgo]] – hIL-17F<BR /> | ||
| - | **[[6ppg]] – hIL-17F + antibody<BR /> | + | **[[6ppg]], [[8ruu]] – hIL-17F + antibody<BR /> |
**[[3jvf]], [[6hg4]], [[6hg9]] - hIL-17F + IL-17 receptor α | **[[3jvf]], [[6hg4]], [[6hg9]] - hIL-17F + IL-17 receptor α | ||
| Line 166: | Line 204: | ||
**[[3wo2]] – hIL-18 <BR /> | **[[3wo2]] – hIL-18 <BR /> | ||
| - | **[[ | + | **[[4xfs]], [[4xft]], [[4xfu]], [[9od7]], [[9od9]] - hIL-18 (mutant) <BR /> |
| - | **[[1j0s]] – hIL-18 - NMR<BR /> | + | **[[1j0s]], [[8urv]] – hIL-18 - NMR<BR /> |
**[[4hjj]] - hIL-18 + antibody<br /> | **[[4hjj]] - hIL-18 + antibody<br /> | ||
**[[2vxt]] - hIL-18 (mutant) + antibody<BR /> | **[[2vxt]] - hIL-18 (mutant) + antibody<BR /> | ||
| Line 174: | Line 212: | ||
**[[3wo3]], [[4r6u]] - hIL-18 + IL-18 receptor<br /> | **[[3wo3]], [[4r6u]] - hIL-18 + IL-18 receptor<br /> | ||
**[[3wo4]] - hIL-18 + IL-18 receptor + IL-18 receptor accessory protein<br /> | **[[3wo4]] - hIL-18 + IL-18 receptor + IL-18 receptor accessory protein<br /> | ||
| + | **[[8j6k]], [[8spb]], [[8sv1]] - hIL-18 + caspase P10, P20 subunits<br /> | ||
*IL-19 | *IL-19 | ||
| Line 187: | Line 226: | ||
**[[2oqp]]– hIL-21 – NMR<BR /> | **[[2oqp]]– hIL-21 – NMR<BR /> | ||
**[[3tgx]] - hIL-21 + IL-21 receptor α (mutant) <BR /> | **[[3tgx]] - hIL-21 + IL-21 receptor α (mutant) <BR /> | ||
| + | **[[9e2t]] - hIL-21 (mutant) + ILR-21 + ILR-2 gamma<BR /> | ||
| + | **[[8ent]] - hIL-21 (mutant) + ILR-21 (mutant) + ILR-2 gamma (mutant) <BR /> | ||
*IL-22 | *IL-22 | ||
| Line 194: | Line 235: | ||
**[[3dlq]], [[3dgc]] - hIL-22 residues 29-179 (mutant) + IL-22 receptor α1<br /> | **[[3dlq]], [[3dgc]] - hIL-22 residues 29-179 (mutant) + IL-22 receptor α1<br /> | ||
**[[3q1s]] - hIL-22 residues 29-179 (mutant) + antibody<br /> | **[[3q1s]] - hIL-22 residues 29-179 (mutant) + antibody<br /> | ||
| + | **[[6weo]] - hIL-22 + IL-22 receptor + IL-10 receptor <br /> | ||
**[[4o6k]] – IL-22 – zebra fish<BR /> | **[[4o6k]] – IL-22 – zebra fish<BR /> | ||
| Line 207: | Line 249: | ||
**[[6gg1]] - hIL-24<br /> | **[[6gg1]] - hIL-24<br /> | ||
**[[6df3]] - hIL-24 + IL—22 receptor α1 + IL-20 receptor β<br /> | **[[6df3]] - hIL-24 + IL—22 receptor α1 + IL-20 receptor β<br /> | ||
| + | |||
| + | *IL-25 | ||
| + | |||
| + | **[[7uwj]], [[7uwk]] - hIL-25 + IL—17 receptor b – Cryo EM<br /> | ||
| + | **[[7uwl]] - hIL-25 + IL—17 receptor a + IL—17 receptor b – Cryo EM<br /> | ||
| + | |||
| + | *IL-27 | ||
| + | |||
| + | **[[8xwy]] - hIL-27 α and β <br /> | ||
| + | **[[7u7n]], [[8d85]] - hIL-27 + IL—27 receptor a + IL-6 receptor b – Cryo EM<br /> | ||
| + | **[[7zxk]] - hIL-27 + antibody<br /> | ||
| + | **[[7zg0]] - mIL-27 + IL—27 receptor a <br /> | ||
| + | **[[7z0l]] - mIL-27 + IL—27 receptor a + IL-6 receptor b – Cryo EM<br /> | ||
*IL-28 | *IL-28 | ||
| Line 220: | Line 275: | ||
**[[2kll]] - hIL-33 residues 110-270 - NMR<BR /> | **[[2kll]] - hIL-33 residues 110-270 - NMR<BR /> | ||
| + | **[[4kc3]] - hIL-33 + IL—1 receptor-like 1<br /> | ||
| + | **[[5iv4]] - mIL-33 + IL—1 receptor-like 1 + IL-1 receptor accessory protein<br /> | ||
| + | **[[8q5r]] - mIL-33 + alarmin release inhibitor<br /> | ||
*IL-34 | *IL-34 | ||
| Line 238: | Line 296: | ||
**[[6ncu]], [[5hn1]] - hIL-37<br /> | **[[6ncu]], [[5hn1]] - hIL-37<br /> | ||
| + | |||
| + | *IL-38 | ||
| + | |||
| + | **[[8q3j]] - mIL-38 + antibody<br /> | ||
| + | |||
| + | |||
}} | }} | ||
[[Category: Topic Page]] | [[Category: Topic Page]] | ||
Current revision
3D structures of interleukin
Updated on 05-October-2025
